Prostate Cancer Clinical Trial
Preliminary Evaluation of Uptake in Bone Metastases and Biodistribution of [68Ga]P15-041
Summary
A phase1 study to demonstrate [68Ga]P15-041 binding to bone metastases in prostate cancer and determination of human dosimetry.
Eligibility Criteria
Inclusion Criteria:
histologically confirmed prostate cancer. known or suspected bone metastases referred for a clinical [99mTc]MDP scan
Exclusion Criteria:
Estimated creatinine clearance (GFR) < 30 mL/min (calculated), history of hyperparathyroidism, • Inability to tolerate imaging procedures in the opinion of an investigator or treating physician, • Any current medical condition, illness, or disorder as assessed by medical record review and/or self-reported that is considered by a physician investigator to be a condition that could compromise participant safety or successful participation in the study
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Philadelphia Pennsylvania, , United States
How clear is this clinincal trial information?